New study to test treatments for back pain in pregnancy
Back pain in pregnancy affects many women and can interfere with everyday activities. A new study, called the EASE BACK study (Evaluating Acupuncture and Standard care for pregnant womEn with BACK pain), is testing treatment options for this problem, with the help of funding from the National Institute of Health Research.
Clinicians and researchers at Keele, Staffordshire and Birmingham Universities are working together to offer treatments to 180 pregnant women with back pain in the local area.
The EASE BACK study is suitable for women with back pain who are between 13 and 31 weeks pregnant, and who are planning on giving birth under the care of The University Hospital of North Staffordshire. The study is testing the effectiveness of advice and education, exercise and acupuncture.
Back pain during pregnancy is common and can affect daily activities, work and sleep. At the moment usual care for pregnant women with back pain typically involves advice about things that they can do to help ease their pain, for example, changes in posture and simple exercises to do at home. But acupuncture may be a treatment that could also help. It is already recommended in UK guidelines for treating back pain generally. Currently, some midwives and physiotherapists already use it to treat pregnant women with back pain. However, this area has not been researched and therefore it is not known if acupuncture is better than usual care for pregnant women.
In order to understand whether acupuncture can really help pregnant women with back pain, the research team would like to invite pregnant women with back pain to participate in this important study. One group of women will be selected randomly to receive ‘usual care’ and another group will receive ‘usual care plus acupuncture’ in what is called a ‘randomised trial’. For more information about the EASE BACK study please contact Mel Holden on 01782 733921.
HTA 1. The National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme funds research about the effectiveness, costs, and broader impact of health technologies for those who use, manage and provide care in the NHS. It is the largest NIHR Programme and publishes the results of its research in the Health Technology Assessment journal, with over 600 issues published to date. The journal’s 2011 Impact Factor (4.255) ranked it in the top 10% of medical and health-related journals. All issues are available for download, free of charge, from the website. The HTA Programme is funded by the NIHR, with contributions from the CSO in Scotland, NISCHR in Wales, and the HSC R&D Division, Public Health Agency in Northern Ireland.www.hta.ac.uk.
2. The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government’s strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, Programmes, centres of excellence and systems represent the most integrated health research system in the world. For further information, visit the NIHR website (www.nihr.ac.uk). This article/paper/report presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.